Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, ...

After examining Johnson & Johnson, the following trends can be inferred: A Price to Earnings ratio of 24.93 significantly below the industry average by 0.75x suggests undervaluation. This can make the ...

Pharma Logistics ( a leader in pharmaceutical compliance and reverse distribution, is pleased to announce the appointment of ...

Charles Barker, one of the Cannabis Regulatory Commission’s most outspoken critics of big cannabis corporations, is being ...

Clarity Pharmaceuticals Ltd ( ASX:CU6 ) is possibly approaching a major achievement in its business, so we would ...

AscellaHealth Expands Global Leadership Team: Specialty Pharmaceutical Experts with Manufacturer and Payer Expertise Propel International Growth ...

Biotechnology is at the forefront of innovation, transforming healthcare and pushing the boundaries of what’s possible. As groundbreaking discoveries unfold daily—from cutting-edge therapies to ...

Amphastar Pharmaceuticals offers growth potential with diverse products, a solid balance sheet, and manageable risks. Find ...

Effective provider segmentation can make or break a new drug launch, and can also improve the lifecycle of existing portfolio ...

Alison has more than 35 years of broad experience delivering clinical trials to sponsors with a patient centric mindset.

Lynne Merriam was working as a nurse in an emergency room in the early 1990s when a leadership position in the research ...